Zobrazeno 1 - 10
of 324
pro vyhledávání: '"Ronghe, M."'
Autor:
Fenwick N; Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom., Weston R; Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom., Wheatley K; Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom., Hodgson J; Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom., Marshall L; The Royal Marsden, Sutton, United Kingdom., Elliott M; Leeds Teaching Hospital, St James University Hospital, Leeds, United Kingdom., Makin G; Royal Manchester Children's Hospital, Manchester, United Kingdom., Ng A; Bristol Royal Hospital for Children, Bristol, United Kingdom., Brennan B; Royal Manchester Children's Hospital, Manchester, United Kingdom., Lowis S; Bristol Royal Hospital for Children, Bristol, United Kingdom., Adamski J; Birmingham Children's Hospital, Birmingham, United Kingdom., Kilday JP; Royal Manchester Children's Hospital, Manchester, United Kingdom., Cox R; Bristol Royal Hospital for Children, Bristol, United Kingdom., Gattens M; Addenbrookes Hospital, Cambridge, United Kingdom., Moore A; Queensland Children's Hospital, Brisbane, QLD, Australia., Trahair T; Sydney Children's Hospital, Sydney, NSW, Australia., Ronghe M; Royal Hospital for Children, Glasgow, United Kingdom., Campbell M; Royal Children's Hospital, Melbourne, VIC, Australia., Campbell H; Royal Manchester Children's Hospital, Manchester, United Kingdom., Williams MW; Royal Children's Hospital, Melbourne, VIC, Australia., Kirby M; Michael Rice Cancer Centre, Women's and Children's Hospital, North Adelaide, SA, Australia., Van Eijkelenburg N; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Keely J; Children's Cancer Trials Team, Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom., Scarpa U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Stavrou V; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Fultang L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Booth S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Cheng P; Bio-Cancer Treatment International, Hong Kong Science Park, Hong Kong, Hong Kong SAR, China., De Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Mussai F; Birmingham Children's Hospital, Birmingham, United Kingdom.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Jan 31; Vol. 14, pp. 1296576. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024).
Autor:
Kuah XYC; Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, UK.; Department of Paediatric Endocrinology, Royal Hospital for Children, 1345 Govan Road, Glasgow, G51 4TF, UK., Lucas-Herald AK; Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, UK.; Department of Paediatric Endocrinology, Royal Hospital for Children, 1345 Govan Road, Glasgow, G51 4TF, UK., McCarrison S; Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, UK.; Department of Paediatric Endocrinology, Royal Hospital for Children, 1345 Govan Road, Glasgow, G51 4TF, UK., Boyle R; Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, UK.; Department of Paediatric Endocrinology, Royal Hospital for Children, 1345 Govan Road, Glasgow, G51 4TF, UK., Adey C; Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Amato-Watkins A; Department of Paediatric Neurosurgery, Royal Hospital for Children, Glasgow, UK., Bhattathiri P; Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK., Campbell E; Department of Paediatric Neurosurgery, Royal Hospital for Children, Glasgow, UK., Cowie F; Beatson West of Scotland Cancer Centre, Glasgow, UK., Dorris L; Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Fulton B; Beatson West of Scotland Cancer Centre, Glasgow, UK., Mcintosh D; Department of Paediatric Oncology, Royal Hospital for Children, Glasgow, UK., Murphy D; Department of Paediatric Oncology, Royal Hospital for Children, Glasgow, UK., Ronghe M; Department of Paediatric Oncology, Royal Hospital for Children, Glasgow, UK., O'Kane R; Department of Paediatric Neurosurgery, Royal Hospital for Children, Glasgow, UK., Todd L; Department of Paediatric Neurosurgery, Royal Hospital for Children, Glasgow, UK., Sangra M; Department of Paediatric Neurosurgery, Royal Hospital for Children, Glasgow, UK., Sastry J; Department of Paediatric Oncology, Royal Hospital for Children, Glasgow, UK., Millar E; Department of Ophthalmology, Royal Hospital for Children, Glasgow, UK., Hassan S; Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK., Shaikh MG; Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, UK. Guftar.shaikh@ggc.scot.nhs.uk.; Department of Paediatric Endocrinology, Royal Hospital for Children, 1345 Govan Road, Glasgow, G51 4TF, UK. Guftar.shaikh@ggc.scot.nhs.uk.
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2024 Jan; Vol. 166 (1), pp. 51-57. Date of Electronic Publication: 2024 Jan 15.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brock PR, Maibach R, Childs M, Rajput K, Roebuk D, Sullivan MJ, Laithier V, Ronghe M, Dall'Igna P, Hiyama E, Brichard B
Publikováno v:
N Engl J Med, Vol. 25, no.378, p. 2376-2385 (2018)
Sodium thiosulfate for protection from cisplatin-induced hearing loss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1493::de0442e557cca78f69ddf2ed6a9d88dc
https://hdl.handle.net/2078.1/213039
https://hdl.handle.net/2078.1/213039
Autor:
Cameron AL; Bristol Haematology and Oncology Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom. Electronic address: Alison.Cameron@UHBW.nhs.uk., Elze MC; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Casanova M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Geoerger B; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, University Paris-Saclay, INSERM U1015, Villejuif, France., Gaze MN; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Minard-Colin V; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, University Paris-Saclay, INSERM U1015, Villejuif, France., McHugh K; Department of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom., van Rijn RR; Department of Radiology and Nuclear Medicine, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands., Kelsey A; Department of Paediatric Histopathology, Manchester University NHS Foundation Trust, Royal Manchester Children's Hospital, Manchester, United Kingdom., Martelli H; Department of Paediatric Surgery, Hôpital Bicêtre-Hôpitaux Universitaires Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Paris, France., Mandeville H; Department of Radiotherapy, the Royal Marsden NHS Foundation Trust, and the Institute of Cancer Research, Sutton, United Kingdom., Bisogno G; Department of Women's and Children's Health, University of Padova, Padova, Italy., Lowis S; Department of Paediatric and Adolescent Oncology, Bristol Royal Hospital for Children, Bristol, United Kingdom., Ronghe M; Department of Paediatric Oncology, Royal Hospital for Children, Glasgow, United Kingdom., Orbach D; SIREDO Oncology Center, Institut Curie, PSL University, Paris, France., Guizani C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Fürst-Recktenwald S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Chisholm JC; Children and Young People's Unit, the Royal Marsden NHS Foundation Trust, and the Institute of Cancer Research, Sutton, United Kingdom., Merks JHM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Emma Children's Hospital-Academic Medical Center (EKZ-AMC), Amsterdam, the Netherlands.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Nov 15; Vol. 111 (4), pp. 968-978. Date of Electronic Publication: 2021 Jul 01.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thakur, Neeraj S.1 (AUTHOR), Rus, Iulia1 (AUTHOR), Herbert, Aidan2 (AUTHOR), Zallocchi, Marisa3 (AUTHOR), Chakrabarty, Brototi1 (AUTHOR), Joshi, Aditya D.1 (AUTHOR), Lomeo, Joshua2 (AUTHOR), Agrahari, Vibhuti1 (AUTHOR) vibhuti-agrahari@ouhsc.edu
Publikováno v:
Journal of Nanobiotechnology. 8/13/2024, Vol. 22 Issue 1, p1-23. 23p.
Aims: To evaluate OS and EFS of paediatric sarcoma patients with an interest in comparing metastatic cases with non-metastatic cases, and compiling statistics on treatment methods.\ud \ud Methods: Information was obtained from patient notes in the Sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::22f0ff2613cd2a7aaad358c8ce37a78d
https://eprints.gla.ac.uk/102717/1/102717.pdf
https://eprints.gla.ac.uk/102717/1/102717.pdf
Autor:
Murray MJ; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Ajithkumar T; Department of Medical Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Harris F; Department of Medical Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Williams RM; Department of Paediatric Endocrinology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Jalloh I; Department of Neurosurgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Cross J; Department of Neuroradiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Ronghe M; Department of Paediatric Haematology and Oncology, Royal Hospital for Children, Glasgow, UK., Ward D; Department of Pathology, University of Cambridge, Cambridge, UK., Scarpini CG; Department of Pathology, University of Cambridge, Cambridge, UK., Nicholson JC; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Coleman N; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2020 Apr 13; Vol. 2 (1), pp. vdaa048. Date of Electronic Publication: 2020 Apr 13 (Print Publication: 2020).
CNS Germ Cell Tumors: Molecular Advances, Significance in Risk Stratification and Future Directions.
Autor:
Zhou, Jiajun1 (AUTHOR) chow816@mail.ccmu.edu.cn, Wu, Chenxing1 (AUTHOR), Li, Shouwei1 (AUTHOR) lishouwei@ccmu.edu.cn
Publikováno v:
Brain Sciences (2076-3425). May2024, Vol. 14 Issue 5, p445. 20p.